Question 1

Do you represent petitioners or patent owners?

Accepted Answer

Both, and we consider that essential. We have briefed and argued the same issues from each side: institution discretion, section 325(d) overlap, claim construction, and real-party-in-interest. That lets us anticipate the strongest version of the opposing position before it is filed.

Question 2

How does PTAB strategy interact with district court litigation?

Accepted Answer

Inseparably. Institution decisions increasingly turn on the state of parallel litigation, including trial dates, invalidity contentions, stipulations, and claim-construction positions taken in court. A petition drafted without a litigation-wide view creates risks that surface months later, when they are hardest to fix.

Question 3

When does ex parte reexamination make more sense than an IPR?

Accepted Answer

More often than most challengers assume. Reexamination is often the better path where the one-year time bar has run, where estoppel exposure matters, or where discretionary-denial risk at the PTAB is elevated. The right answer depends on timing, the prior art, and the posture of any parallel litigation.

Question 4

Is this analytics platform legal advice?

Accepted Answer

No. The platform is an independent educational resource built on the USPTO's published statistics. It does not constitute legal advice and does not create an attorney-client relationship. Always consult qualified patent counsel about your specific matter.

About Us